Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-20-057069

Chief Executive Officer sold 10,000 shares at an average $136.57 ($1,365,702)

  • Chief Executive Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Saxonov Serge · Chief Executive Officer

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-02 Exercise or conversion : show line 1 in the form +6,250 $1.20 $7,500 973,431 D
2020-11-02 Exercise or conversion : show line 2 in the form +826 $5.04 $4,163 974,257 D
2020-11-02 Sale : show line 3 in the form −1,624 $135.45 $219,978 972,633 D
2020-11-02 Sale : show line 4 in the form −4,052 $136.13 $551,587 968,581 D
2020-11-02 Sale : show line 5 in the form −500 $137.10 $68,552 968,081 D
2020-11-02 Sale : show line 6 in the form −900 $138.54 $124,686 967,181 D
2020-11-03 Exercise or conversion : show line 7 in the form +2,924 $5.04 $14,737 970,105 D
2020-11-03 Sale : show line 8 in the form −200 $135.54 $27,107 969,905 D
Open-market sales · 10,000 sh · avg $136.57 · $1,365,702

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-11-02 Exercise or conversion : show line 12 in the form Stock Option (right to buy) −6,250 $1.20 2027-10-18 6,250 116,110 D
2020-11-02 Exercise or conversion : show line 13 in the form Stock Option (right to buy) −826 $5.04 2028-11-02 826 131,189 D
2020-11-03 Exercise or conversion : show line 14 in the form Stock Option (right to buy) −2,924 $5.04 2028-11-02 2,924 128,265 D
Loading xslF345X03/doc4.xml…